Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size, Share, Trends and Forecast 2019-2025

Description

The global Gastro Esophageal Reflux Disease (GERD) Drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Gastro Esophageal Reflux Disease (GERD) Drug market based on company, product type, end user and key regions.

This report studies the global market size of Gastro Esophageal Reflux Disease (GERD) Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Gastro Esophageal Reflux Disease (GERD) Drug in these regions.
This research report categorizes the global Gastro Esophageal Reflux Disease (GERD) Drug market by top players/brands, region, type and end user. This report also studies the global Gastro Esophageal Reflux Disease (GERD) Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
Novartis AG
GlaxoSmithKline
Merck
Medtronic

Market size by Product
H2 Receptor Antagonist
Proton Pump Inhibitor (PPi)
Antacids
Market size by End User
Hospital
Clinic
Medical Center
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Gastro Esophageal Reflux Disease (GERD) Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Gastro Esophageal Reflux Disease (GERD) Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Gastro Esophageal Reflux Disease (GERD) Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Gastro Esophageal Reflux Disease (GERD) Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Gastro Esophageal Reflux Disease (GERD) Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Gastro Esophageal Reflux Disease (GERD) Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENT

Table of Contents

1 Study Coverage
1.1 Gastro Esophageal Reflux Disease (GERD) Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate by Product
1.4.2 H2 Receptor Antagonist
1.4.3 Proton Pump Inhibitor (PPi)
1.4.4 Antacids
1.5 Market by End User
1.5.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Medical Center
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size
2.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue 2014-2025
2.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales 2014-2025
2.2 Gastro Esophageal Reflux Disease (GERD) Drug Growth Rate by Regions
2.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Regions
2.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Gastro Esophageal Reflux Disease (GERD) Drug Sales by Manufacturers
3.1.1 Gastro Esophageal Reflux Disease (GERD) Drug Sales by Manufacturers
3.1.2 Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Manufacturers
3.1.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Concentration Ratio (CR5 and HHI)
3.2 Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Manufacturers
3.2.1 Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Manufacturers (2014-2019)
3.2.2 Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Manufacturers (2014-2019)
3.3 Gastro Esophageal Reflux Disease (GERD) Drug Price by Manufacturers
3.4 Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Base Distribution, Product Types
3.4.1 Gastro Esophageal Reflux Disease (GERD) Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Product Type
3.4.3 Date of International Manufacturers Enter into Gastro Esophageal Reflux Disease (GERD) Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Product
4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Product
4.3 Gastro Esophageal Reflux Disease (GERD) Drug Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Breakdown Data by End User

6 North America
6.1 North America Gastro Esophageal Reflux Disease (GERD) Drug by Countries
6.1.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Countries
6.1.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Gastro Esophageal Reflux Disease (GERD) Drug by Product
6.3 North America Gastro Esophageal Reflux Disease (GERD) Drug by End User

7 Europe
7.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug by Countries
7.1.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Countries
7.1.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug by Product
7.3 Europe Gastro Esophageal Reflux Disease (GERD) Drug by End User

8 Asia Pacific
8.1 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug by Countries
8.1.1 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Countries
8.1.2 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug by Product
8.3 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug by End User

9 Central & South America
9.1 Central & South America Gastro Esophageal Reflux Disease (GERD) Drug by Countries
9.1.1 Central & South America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Countries
9.1.2 Central & South America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Gastro Esophageal Reflux Disease (GERD) Drug by Product
9.3 Central & South America Gastro Esophageal Reflux Disease (GERD) Drug by End User

10 Middle East and Africa
10.1 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug by Countries
10.1.1 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Countries
10.1.2 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug by Product
10.3 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug by End User

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
11.1.5 Pfizer Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Company Business Overview
11.2.3 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
11.2.5 Novartis AG Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 Company Business Overview
11.3.3 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
11.3.5 GlaxoSmithKline Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Company Business Overview
11.4.3 Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Merck Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
11.4.5 Merck Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Details
11.5.2 Company Business Overview
11.5.3 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Products Offered
11.5.5 Medtronic Recent Development

12 Future Forecast
12.1 Gastro Esophageal Reflux Disease (GERD) Drug Market Forecast by Regions
12.1.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Regions 2019-2025
12.1.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Regions 2019-2025
12.2 Gastro Esophageal Reflux Disease (GERD) Drug Market Forecast by Product
12.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Product 2019-2025
12.2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Product 2019-2025
12.3 Gastro Esophageal Reflux Disease (GERD) Drug Market Forecast by End User
12.4 North America Gastro Esophageal Reflux Disease (GERD) Drug Forecast
12.5 Europe Gastro Esophageal Reflux Disease (GERD) Drug Forecast
12.6 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Forecast
12.7 Central & South America Gastro Esophageal Reflux Disease (GERD) Drug Forecast
12.8 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gastro Esophageal Reflux Disease (GERD) Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

Choose License Type

Checkout Inquiry Sample